A new research paper was published in , Volume 16, on March 21, 2025, titled "NSD2-epigenomic reprogramming and maintenance of plasma cell phenotype in t(4;14) myeloma." ...

For GC patients, the inclusion criteria included: (1) GC patients confirmed by pathological examination and with D2 lymphadenectomy, (2) patients with plasma samples prior to surgery, (3) patients who ...

The pramiry materials and methods used in the experiments were listed below, and the flow chart ... aspirated as plasma and stored at −80°C for downstream analysis. The HUVEC cells were incubated ...

The selection process of the studies is depicted in a flowchart (Supplementary Figure ... remains preferred for first-line intensive treatment; 3. Drug resistance monitoring and management: Serial ...

Researchers have developed a cutting-edge chip technology capable of precisely mimicking the interactions between cancer cells and blood vessels, akin to the human body environment. This innovation is ...

Richardson, has published promising findings from the past seven years of research into a new approach for the treatment of highly aggressive brain tumors.

Kanazawa University and colleagues have developed a promising new approach to cancer treatment. By using tiny, naturally ...

Treatment of B-cell ... therapy and reduce relapses”. B-cell Acute Lymphoblastic Leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common ...

or chimeric antigen receptor T-cell therapy, could be effective for treating Gavin’s type of brain cancer. The treatment programs a person’s own T cells — immune cells that usually fight ...

The breakthrough method could improve treatment strategies for diseases like cancer, they say. The system, called scNET (pronounced sek-net), short for single-cell network, “uses AI in a ...